Whole-body MRI in oncology: acquisition protocols, current guidelines, and beyond

Radiol Med. 2024 Sep;129(9):1352-1368. doi: 10.1007/s11547-024-01851-6. Epub 2024 Jul 11.

Abstract

Acknowledging the increasing use of whole-body magnetic resonance imaging (WB-MRI) in the oncological setting, we conducted a narrative review focusing on practical aspects of the examination and providing a synthesis of various acquisition protocols described in the literature. Firstly, we addressed the topic of patient preparation, emphasizing methods to enhance examination acceptance. This included strategies for reducing anxiety and patient distress, improving staff-patient interactions, and increasing overall patient comfort. Secondly, we analysed WB-MRI acquisition protocols recommended in existing imaging guidelines, such as MET-RADS-P, MY-RADS, and ONCO-RADS, and provided an overview of acquisition protocols reported in the literature regarding other expanding applications of WB-MRI in oncology, in patients with breast cancer, ovarian cancer, melanoma, colorectal and lung cancer, lymphoma, and cancers of unknown primary. Finally, we suggested possible acquisition parameters for whole-body images across MR systems from three different vendors.

Keywords: Diffusion magnetic resonance imaging; Li-Fraumeni syndrome; Melanoma; Multiple myeloma; Prostate cancer; Whole body imaging.

Publication types

  • Review

MeSH terms

  • Humans
  • Magnetic Resonance Imaging* / methods
  • Neoplasms* / diagnostic imaging
  • Practice Guidelines as Topic*
  • Whole Body Imaging* / methods